Phase Ia and lb studies of the novel carcinoembryonic antigen (CEA) 1-cell bispecific (CEA CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary efficacy and safety in patients with metastatic colorectal cancer (mCRC) Meeting Abstract
| Authors: | Tabernero, J.; Melero, I.; Ros, W.; Argiles, G.; Marabelle, A.; Rodriguez-Ruiz, M. E.; Albanell, J.; Calvo, E.; Moreno, V.; Cleary, J. M.; Eder, J. P.; Karanikas, V.; Bouseida, S.; Sandoval, F.; Sabanes, D.; Sreckovic, S.; Hurwitz, H.; Paz-Ares, L. G.; Suarez, J. M. S.; Segal, N. H. |
| Abstract Title: | Phase Ia and lb studies of the novel carcinoembryonic antigen (CEA) 1-cell bispecific (CEA CD3 TCB) antibody as a single agent and in combination with atezolizumab: Preliminary efficacy and safety in patients with metastatic colorectal cancer (mCRC) |
| Meeting Title: | 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2017 Jun 2-6 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-05-20 |
| Start Page: | 138s |
| Language: | English |
| ACCESSION: | WOS:000411895705132 |
| DOI: | 10.1200/JCO.2017.35.15_suppl.3002 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3002 -- Source: Wos |
